Previous Article | Next Article ![]()
Journal of Virology, August 2005, p. 9821-9830, Vol. 79, No. 15
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.15.9821-9830.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
and PKC
Division of Infectious Diseases and Program in Translational Immunovirology and Biodefense,1 Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota2
Received 18 January 2005/ Accepted 27 April 2005
Latently human immunodeficiency virus (HIV)-infected memory CD4+ T cells represent the major obstacle to eradicating HIV from infected patients. Antigens, T-cell receptor (TCR) ligation, and phorbol esters can reactivate HIV from latency in a protein kinase C (PKC)-dependent manner; however, it is unknown which specific PKC isoforms are required for this effect. We demonstrate that constitutively active (CA) forms of both PKC
, PKC
A148E, and PKC
, PKC
A25E, induce HIV long terminal repeat (LTR)-dependent transcription in Jurkat and primary human CD4+ T cells and that both PKC
A148E and PKC
A25E cause HIV reactivation in J1.1 T cells. Suppression of both PKC
and PKC
with short hairpinned (sh) RNA inhibited CD3/CD28-induced HIV LTR-dependent transcription and HIV reactivation in J1.1 T cells. Both prostratin and phorbol myristate 13-acetate induced HIV LTR-dependent transcription and HIV reactivation in J1.1 T cells that was blocked by shRNA against either PKC
or PKC
. Since suppression of PKC
and PKC
together has no greater inhibitory effect on HIV reactivation than inhibition of PKC
alone, our data confirm that PKC
and PKC
act in sequence. The requirement for PKC
and PKC
for prostratin-induced HIV reactivation and the ability of selective PKC
or PKC
agonists to induce HIV transcription indicate that these PKC isoforms are important targets for therapeutic drug design.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»